Article Details
Retrieved on: 2018-03-31 23:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Meditor <b>Group</b> Ltd increased its stake in Esperion Therapeutics Inc (ESPR) by 1.22% based on its latest 2017Q4 regulatory filing with the SEC. Meditor <b>Group</b> Ltd bought 27,900 shares as the company's stock rose 22.41% while stock markets declined. The institutional investor held 2.32M shares of the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here